Product
Semaglutide D
Aliases
Semaglutide D, 1.0 mg/mL
3 clinical trials
5 indications
Indication
Healthy VolunteersIndication
Type 2Indication
Healthy Control ParticipantsIndication
Type 2 DiabetesIndication
ObesityClinical trial
A Study to Demonstrate Bioequivalence Between Semaglutide Formulation for the DV3396 Pen-injector and the Formulation for the PDS290 Semaglutide Pen-injectorStatus: Completed, Estimated PCD: 2022-08-30
Clinical trial
A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-06-28
Clinical trial
The Effect of Oral Semaglutide 50 mg Once-daily on Energy Intake, Gastric Emptying, Appetite, Control of Eating and Pharmacokinetics in Participants With ObesityStatus: Completed, Estimated PCD: 2022-09-29